Serge Saxonov, Chief Executive Officer at 10x Genomics, Inc. (TXG), sold 2,000 shares at $55.15 ($110K) on 2023-12-14, disclosed to the SEC on 2023-12-18.
Scheduled sale ($110k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.39 | 300 | $16K | 14.8% |
| 2 | $55.15 | 1,700 | $94K | 85.2% |
| Total | $55.04 avg | 2,000 | $110K | 100% |
| Filing → |
| TXG | SELL | 2026-08-26 | $1.2M | — | Filing → |
| TXG | SELL | 2026-06-24 | $1.0M | — | Filing → |
| TXG | SELL | 2026-05-27 | $709K | — | Filing → |